# Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes

> **NCT00117780** · PHASE4 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 520 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** insulin detemir
- **DRUG:** insulin aspart

## Key facts

- **NCT ID:** NCT00117780
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 520 (ACTUAL)
- **Last updated:** 2017-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00117780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00117780, "Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00117780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*